Hypertension and alterations in left ventricular structure and geometry in African Americans: the Jackson Heart Study

Marwah Abdalla1, John N Booth2, Keith M Diaz1

  • 1Department of Medicine, Columbia University Medical Center, New York, NY, USA.

Insights

Hypertension significantly increases the risk of abnormal left ventricular (LV) structure in African Americans. This study found hypertension strongly associated with concentric hypertrophy, a concerning LV abnormality.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Public Health

Background:

  • African Americans (AAs) exhibit higher hypertension-related cardiovascular risks than whites.
  • Abnormal left ventricular (LV) structure may underlie these disparities.

Purpose of the Study:

  • To investigate the association between prevalent hypertension and LV structural abnormalities.
  • Specifically examining concentric remodeling (CR), eccentric hypertrophy, and concentric hypertrophy (CH) in AAs.

Main Methods:

  • Analysis of 4721 participants from the Jackson Heart Study.
  • Hypertension defined as clinic blood pressure ≥140/90 mm Hg or medication use.
  • Multivariable analysis adjusted for relevant covariates.

Main Results:

  • Prevalent hypertension was linked to increased odds of CR (OR=1.78), eccentric hypertrophy (OR=1.68), and CH (OR=3.86).
  • Concentric hypertrophy showed the strongest association with hypertension.
  • The findings were statistically significant after multivariable adjustment.

Conclusions:

  • Hypertension is significantly associated with abnormal LV structure in a population-based sample of African Americans.
  • Concentric hypertrophy is a particularly prevalent LV abnormality in hypertensive AAs.
  • These findings highlight the importance of hypertension management for preventing cardiac structural changes in this population.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
708
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
821
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.1K